U.S. Capitol building at sunrise
Congress is on track to end its current session next week without addressing drug manufacturers’ denials of 340B pricing when covered entities contract with outside pharmacies.

117th Congress Nears End With No 340B Contract Pharmacy Fix Expected

The 117th Congress appears destined to end without further action on the 340B program.

The House and Senate are on track to finish all work for the year by no later than Friday, Dec. 23. According to news reports yesterday, they are expected to pass an omnibus appropriations bill to fund the entire government through Sept. 30, 2023, and then recess for the holidays.

The 117th Congress appears destined to end without further action on the 340B program.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

×

*Sign up for news summaries and alerts from 340B Report

Site Footer